Survivorship in systemic lupus erythematosus. effect of antibody to extractable nuclear antigen
Open Access
- 1 January 1981
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 24 (1), 54-59
- https://doi.org/10.1002/art.1780240109
Abstract
The course of 81 patients with systemic lupus erythematosus (SLE) who had sera tested for antibody to extractable nuclear antigen (ENA) was studied to determine the effect of the presence of antiENA antibody on survivorship. There were no differences in percent survival between the patients with and without antibody to ENA or those with and without antibody to the ribonucleoprotein (RNP) component of ENA. We conclude that there is no prognostic advantage to the presence of either antiENA or antiRNP antibody in patients with SLE.This publication has 23 references indexed in Scilit:
- The Measurement of Antibodies to Extractable Nuclear AntigenAmerican Journal of Clinical Pathology, 1979
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Systemic Lupus Erythematosus in the CommunityArchives of Internal Medicine, 1974
- Duration and Death in Systemic Lupus ErythematosusPublished by American Medical Association (AMA) ,1974
- THE NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSISMedicine, 1971
- Survivorship in systemic lupus erythematosus: Relationship to race and pregnancyArthritis & Rheumatism, 1969
- Systemic Lupus ErythematosusArchives of Internal Medicine, 1964
- NEW CLINICAL CONCEPT OF SYSTEMIC LUPUS ERYTHEMATOSUSJournal of the American Medical Association, 1959
- Factors Influencing the Course and Prognosis of Systemic Lupus ErythematosusNew England Journal of Medicine, 1959
- Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosusJournal of Chronic Diseases, 1955